Skip to content
healthcare.dev

MOTPOLY XR

NDC 73289-0065, lacosamide, capsule, extended release, from Aucta Pharmaceuticals, Inc..

Product NDC
73289-0065
Status
Listed
Labeler
Aucta Pharmaceuticals, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216185
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0065 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE200 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
73289-0065-27328900650260 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (73289-0065-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fb8235b4-4cd3-6f22-e053-6294a90a545c
  • NADAC price for package 73289006502

    GET /v1/drugs/nadac/73289006502

Use it

Look up 73289-0065 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0065 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73289-0065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.